Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

WuXi Biologics To Be ‘World’s No.1’ Biologics Maker

Jan 16 2018

• By Ying Huang

Wuxi Biologic Facility Opening — • Source: WuXi Biologic

Related Content

Authorization Holder Scheme To Shake Up China R&D, Production

Nov 06 2015

China Expects Earlier Start Of National Marketing Authorization Holder System

Jul 21 2017

WuXi Biologics Readies For Hong Kong IPO

Jan 11 2017

WuXi To Lead ‘China First’ Strategy For Lilly’s Novel Cholesterol Drug

Mar 22 2016

Beigene/Boehringer Biomanufacturing Bond Tests China MAH System

Mar 10 2016

WuXi Eyes Growing Biologics Business With New Integrated Center

Jan 20 2016

Election Boost For Taiwan Biopharma Industry?

Jan 27 2016

Asia Attracts Manufacturing Capital As Companies Eye Expanding Needs

Nov 04 2016

Related Companies

WuXi Biologics

TaiMed Biologics, Inc.

Lonza Group AG

Samsung Bioepis Co., Ltd.

Harbin Gloria Pharmaceuticals Co., Ltd.

Arcus Biosciences, Inc.

CANbridge Pharmaceuticals Inc.

Zhejiang Medicine Co., Ltd

Ambrx Biopharma, Inc.

EpimAb Biotherapeutics, Inc.

NovaBridge Biosciences

Roche Holding AG

Emcure Pharmaceuticals Pvt Ltd.

Additional Topics

China Asia Pacific Biologics Business Strategies Commercial Manufacturing

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window